These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hyperlipidemia: scientific basis and principles of intervention. Pyörälä K Rev Port Cardiol; 1990 Nov; 9(11):859-67. PubMed ID: 2078353 [No Abstract] [Full Text] [Related]
26. [Hyperlipidemia and cardiovascular diseases]. Cottini EP Medicina (B Aires); 1992; 52(1):79-80. PubMed ID: 1302296 [No Abstract] [Full Text] [Related]
27. [Dyslipoproteinemia as a coronary risk factor]. Yamamura T Nihon Rinsho; 1994 Aug; 52 Suppl(Pt 2):28-34. PubMed ID: 12439947 [No Abstract] [Full Text] [Related]
28. [Diet therapy of hyperlipidemia]. Yamada N Nihon Rinsho; 1990 Nov; 48(11):2605-12. PubMed ID: 2270028 [No Abstract] [Full Text] [Related]
29. Postprandial dyslipidemia: a risk factor for coronary heart disease. Dallongeville J; Fruchart JC Ann Nutr Metab; 1998; 42(1):1-11. PubMed ID: 9522960 [No Abstract] [Full Text] [Related]
30. Management of postmenopausal women who have hyperlipidemia. Larosa JC Am J Med; 1994 Jun; 96(6A):19S-24S. PubMed ID: 8017461 [TBL] [Abstract][Full Text] [Related]
32. Hyperlipidaemia and coronary risk. Shaper AG Scott Med J; 1991 Oct; 36(5):132. PubMed ID: 1788540 [No Abstract] [Full Text] [Related]
33. [Recent trend in the research of hyperlipidemia in Japan (1). Profiles of primary hyperlipidemia]. Matsuzawa Y; Tarui S Nihon Naika Gakkai Zasshi; 1989 Oct; 78(10):1396-9. PubMed ID: 2600493 [No Abstract] [Full Text] [Related]
34. A look at lipoproteins. Dawson JE J Med Assoc Ga; 1975 Aug; 64(8):320-1. PubMed ID: 1194793 [No Abstract] [Full Text] [Related]
35. Fat cell size and free cholesterol content in adipose tissue of subjects with asymptomatic hyperlipidemia and coronary heart disease. Walldius G Verh Dtsch Ges Inn Med; 1972; 78():1248-53. PubMed ID: 4665509 [No Abstract] [Full Text] [Related]
36. [Description of a special form of postprandial hyperlipidemia: possible cause of premature coronary heart disease]. Wieland E; Walli AK; Niedmann PD; Lohstöter C; Kraemer A; Seidel D Ther Umsch; 1990 Jun; 47(6):492-8. PubMed ID: 2375006 [TBL] [Abstract][Full Text] [Related]
37. [Defective remnant clearance as a risk factor for coronary heart disease]. Wieland E; Walli AK; Niedmann PD; Lohstöter C; Krämer A; Seidel D Klin Wochenschr; 1990; 68 Suppl 22():63-7. PubMed ID: 2087082 [TBL] [Abstract][Full Text] [Related]
38. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913 [TBL] [Abstract][Full Text] [Related]
39. Disturbances in dietary fat metabolism and their role in the development of atherosclerosis. Weintraub M; Charach G; Grosskopf I Biomed Pharmacother; 1997; 51(8):311-3. PubMed ID: 9436521 [TBL] [Abstract][Full Text] [Related]